Sam Tsimikas/X
Aug 23, 2025, 08:14
Sam Tsimikas: NAFCS Score as a Diagnostic Tool for Familial Chylomicronemia Syndrome in Clinical Practice
Sam Tsimikas, Professor of Medicine at the University of California, San Diego, shared a post on X:
“A new paper is out in Lipid Journal validating the NAFCS score for patients with FCS (Familial Chylomicronemia Syndrome- i.e milky plasma) using the Balance genetic data. It will be an alternative method to make the diagnosis of FCS clinically.”
Read the full paper here.
Article: Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study
Authors: Alan S. Brown, Philippe Moulin, Andrew Dibble, Veronica J. Alexander, Lu Li, Daniel Gaudet, Joseph L. Witztum, Sotirios Tsimikas, Robert A.

Stay updated with Hemostasis Today.
Alan S. Brown
Andrew Dibble
Cardiometabolic Health
Chylomicronemia Syndrome
Clinical Validation
Daniel Gaudet
FCS
Genetic Diagnosis
Health
Hematology
Hemostasis Today
Joseph L. Witztum
Lipid Research
LipidJournal
Lu Li
Medicine
NAFCS
Philippe Moulin
Rare Disorders
Robert A.
Sotirios Tsimikas
Veronica J. Alexander
-
Jul 11, 2026, 09:48International Collaboration in Antithrombotic Stewardship – Anticoagulation Forum
-
Jul 11, 2026, 09:45Presenting New CRP-A Data at ISTH 2026 – Pplus Medical Limited
-
Jul 11, 2026, 09:41David Smadja: Addressing the Hidden Threat of Medical Misinformation at ISTH 2026
-
Jul 11, 2026, 09:40Dianne E. van der Wal: The Latest Advances in Hemostasis and Thrombosis on First Day of ISTH 2026
-
Jul 11, 2026, 09:34Heading to ISTH 2026 in Paris Join our session on patient led VTE education – NBCA
-
Jul 11, 2026, 09:33Flora Peyvandi: Empowering the Next Generation of ISTH
-
Jul 11, 2026, 09:28Ruah Alyamany: Surgical and Procedural Bleeding Risk – Perioperative AC guidance
-
Jul 11, 2026, 09:24Habib Bennaceur: New Perspectives on Patient-Centered Hemophilia Care at ISTH 2026
-
Jul 11, 2026, 09:01Nathan Connell: Celebrating 100 Years of von Willebrand Disease at ISTH 2026